| pubmed-article:20576011 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20576011 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:20576011 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:20576011 | lifeskim:mentions | umls-concept:C0272286 | lld:lifeskim |
| pubmed-article:20576011 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:20576011 | lifeskim:mentions | umls-concept:C0085297 | lld:lifeskim |
| pubmed-article:20576011 | lifeskim:mentions | umls-concept:C0456984 | lld:lifeskim |
| pubmed-article:20576011 | lifeskim:mentions | umls-concept:C0678226 | lld:lifeskim |
| pubmed-article:20576011 | lifeskim:mentions | umls-concept:C0493388 | lld:lifeskim |
| pubmed-article:20576011 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:20576011 | pubmed:dateCreated | 2010-12-3 | lld:pubmed |
| pubmed-article:20576011 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20576011 | pubmed:abstractText | Rituximab may cause reactivation of hepatitis B virus (HBV) even in patients with remote HBV infection. Thus, the presence of hepatitis B core antibodies (anti-HBc) was an exclusion criterion for a randomized trial of rituximab for patients with immune thrombocytopenia. A high seroprevalence of anti-HBc observed among patients screened for the trial prompted this substudy to investigate for an association between anti-HBc seropositivity and exposure to intravenous immunoglobulin (IVIG). | lld:pubmed |
| pubmed-article:20576011 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20576011 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20576011 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20576011 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20576011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20576011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20576011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20576011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20576011 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20576011 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20576011 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20576011 | pubmed:issn | 1537-2995 | lld:pubmed |
| pubmed-article:20576011 | pubmed:author | pubmed-author:CrowtherMark... | lld:pubmed |
| pubmed-article:20576011 | pubmed:author | pubmed-author:MeyerRalph... | lld:pubmed |
| pubmed-article:20576011 | pubmed:author | pubmed-author:KeltonJohn... | lld:pubmed |
| pubmed-article:20576011 | pubmed:author | pubmed-author:HeddleNancy... | lld:pubmed |
| pubmed-article:20576011 | pubmed:author | pubmed-author:CarruthersJul... | lld:pubmed |
| pubmed-article:20576011 | pubmed:author | pubmed-author:McLeodAnneA | lld:pubmed |
| pubmed-article:20576011 | pubmed:author | pubmed-author:ArnoldDonald... | lld:pubmed |
| pubmed-article:20576011 | pubmed:author | pubmed-author:DitomassoJuli... | lld:pubmed |
| pubmed-article:20576011 | pubmed:copyrightInfo | © 2010 American Association of Blood Banks. | lld:pubmed |
| pubmed-article:20576011 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20576011 | pubmed:volume | 50 | lld:pubmed |
| pubmed-article:20576011 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20576011 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20576011 | pubmed:pagination | 2577-81 | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:meshHeading | pubmed-meshheading:20576011... | lld:pubmed |
| pubmed-article:20576011 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20576011 | pubmed:articleTitle | Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. | lld:pubmed |
| pubmed-article:20576011 | pubmed:affiliation | Department of Medicine, Michael DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada. arnold@mcmaster.ca | lld:pubmed |
| pubmed-article:20576011 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20576011 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20576011 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
